Aurobindo Pharma gets USFDA final, tentative nod for different strengths of deep vein thrombosis drug Rivaroxaban Ruchika Sharma14 April 2025 11:30 AM ISTAurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and...
Edoxaban as good as Apixaban for VTE prevention in elderly with nonvalvular AF: Study Jacinthlyn Sylvia24 March 2024 8:00 PM ISTIn a recent study that could influence the management of nonvalvular atrial fibrillation among the elderly, recent outcomes unveiled the comparative...
Catheter ablation in very old patients with nonvalvular AF tied to lower incidence of death, CV events Dr. Kamal Kant Kohli25 Aug 2023 10:00 AM ISTJapan: In very old nonvalvular AF (NVAF) patients using direct oral anticoagulants (DOACs), those who underwent atrial fibrillation (AF) ablation...
Medical Bulletin 24/August/2023 Isra Zaman24 Aug 2023 3:30 PM ISTHere are the top medical news of the day:Heart damage in young adulthood linked with sedentary time in childrenHours of inactivity during childhood...
Assessing Catheter ablation in very old patients with nonvalvular atrial fibrillation Isra Zaman24 Aug 2023 9:15 AM ISTNon-valvular atrial fibrillation (NVAF) is a common type of cardiac arrhythmia, specifically an irregular and often rapid heartbeat, that occurs in...
Researchers find "disconnect" between AF patients and their doctors when it came to oral anticoagulation Dr Monish Raut19 Jun 2023 9:45 AM ISTAccording to results of a new prospective cohort research, patients with nonvalvular atrial fibrillation (AF) who are not already taking oral...
DOAC use reduces risk of CKD progression in patients with AF compared with VKA use Dr Kartikeya Kohli25 Feb 2023 9:30 AM ISTA recent study by Marco Trevisan and team found that Direct oral anticoagulant (DOAC) use is associated with a lower risk of chronic kidney disease...
Use of NOACs in diabetes with AF tied to decreased risk of osteoporotic fractures compared to warfarin Dr. Kamal Kant Kohli6 Oct 2022 12:15 AM ISTCHINA: In individuals with type 2 diabetes with atrial fibrillation, usage of non-vitamin K antagonist oral anticoagulants was linked to a decreased...
